MedTrace Logo

Quality of Life in Juvenile Patients With Uveitis

NCT01495767 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 37

Last updated 2011-12-23

No results posted yet for this study

Summary

Data about psychodynamics in uveitis patients are scare. A negative impact of disease is described not only in adult patients with active, but also with quiescent disease. During adolescence even less is known about psychodynamics although this is an especially sensible and challenging stage of life. Given the assumption that juvenile patients with quiescent disease still could suffer from emotional distress, this would require special attention.

In this study the investigators evaluate the impact of juvenile uveitis on HRQoL and attempted to identify clinical and demographic factors contributing to an impaired health status. The investigators limit the study to patients with quiescent uveitis and good visual function in at least one eye to exclude additional negative stressors. As there are no validated uveitis-specific psychometric questionnaires evaluating QoL available yet, the investigators use age-appropriate generic instruments. This should allow obtaining an overview about the adolescents' general Health-related Quality of Life (HRQoL) and whether psychological interventions should be offered to this sensitive patient group.

Conditions

  • Uveitis

Interventions

OTHER

Filling in a psychometric questionnaire

Juvenile patients attending the uveitis are asked to fill in a psychometric questionnaire

Sponsors & Collaborators

  • Medical University of Vienna

    collaborator OTHER

  • Hospital Hietzing

    lead OTHER

Principal Investigators

  • Saskia M Maca, MD · Hospital Hietzing, Vienna + Medical University of Vienna, Vienna

Eligibility

Min Age
11 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Completion
2009-07-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01495767 on ClinicalTrials.gov